25 April 2019 - The European Medicines Agency, one of the EU's biggest regulators, is appealing against a London ruling that has blocked its plans to break a 25-year, £500 million lease of its London headquarters because of Brexit.

In a case that pitches the agency against the Canary Wharf Group, the landlord of London's financial district, the EMA alleges in court filings that a High Court judge erred when he ruled in February that Britain's plans to leave the EU did not legally prevent the agency from using the office.

Landlords fear that the case risks opening the floodgates to companies seeking to abandon multi-million-pound property contracts because of Brexit if the EMA is successful. The appeal has been scheduled for March 2020.

Read Euronews article